Poisonous avoid by all means of second liver disease-resistant " half-hearted "

The overall objective that chronic second liver treats is: Utmost ground is restrained for a long time or eliminate second liver virus. However, be able to bear or endure the obstacle that medicine becomes patient disease-resistant poison to treat a road to go up however, the expert points out, chronic second liver needs long-term treatment, disease-resistant poison treats the time that needs 2 years at least, longer even. Because this control is able to bear or endure,medicine becomes the crucial place that disease-resistant poison treats. Be able to bear or endure once medicine happens, effective to virus remedy can lose curative effect or make curative effect is reduced greatly originally, cause patient virus to rebound then, disease progress; at the same time, be able to bear or endure after medical happening change medicine to perhaps add medical treatment, can increase patient happening to be able to bear or endure medical risk, limitative follow-up treats the choice of plan, make the patient bears heavy psychological burden and mental pressure, still can bring about remedial charge ascendant; to be able to bear or endure repeatedly the confidence that medicine can make the patient loses pair of treatment, the mood is low bring about immune function to drop, make treat the effect to sell at a discount greatly thereby. Psychological expert points out, the second liver patient of more than 60% above has expressed the concern to afore-mentioned problems. Be able to bear or endure in the light of virus medical mutation precaution, the expert formulates 3 old strategy: 1, logical choice nucleotide (acerbity) analogue fights what virus treats to get used to disease. 2, reduce be able to bear or endure medical risk: Poisonous to having disease-resistant cure gets used to the patient of disease, choose disease-resistant poisonous action when initiative cure as far as possible strong, be able to bear or endure the medicaments with medical mutation low occurence rate. Clinical show, had happened be able to bear or endure it is more difficult that patient treatment of medicine treats a patient at the beginning of contrast, one is plant now " therapeutics of add be linked together " , ate a few months to change another medicine again later namely, little harm of benefit of this kind of practice is much, very easy finally generation is able to bear or endure medicine. Clinical data shows, use favour replaces the patient of chronic second liver that treats at the beginning of nucleotide block Wei 5 years, the patient virus of 93% carries a quantity to fall to cannot measure a level, 5 years accumulative total is able to bear or endure medical occurence rate is only 1.2% . 3, raise sex of patient comply with: Be able to bear or endure because do not deserve to add up to cure,medical happening often is, casual inspection. Accordingly, the patient is using nucleotide (acerbity) during analogue has treatment, should follow the doctor's advice on time, full amount takes drug, restrain virus as far as possible in lowermost level. In addition, still should detect regularly during cure, every 3 months detect HBV DNA level. (the exercitation edits: Plum apricot)